SynthesisEuropean journal of clinical pharmacology2016

First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.

Kathrin Kuhr et al.PubMed ↗Publisher ↗

No numbers read from the abstract.